Champions Oncology, Inc.
CSBR
$5.26
-$0.20-3.66%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -96.76% | -226.97% | 161.24% | 76.24% | -140.82% |
| Total Depreciation and Amortization | -5.87% | -4.48% | -0.28% | -9.14% | -1.01% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.14% | 33.90% | 34.86% | -17.70% | 13.23% |
| Change in Net Operating Assets | -9.34% | 26.59% | -1,610.05% | -97.42% | 257.15% |
| Cash from Operations | -49.22% | 22.82% | -389.17% | -91.26% | 1,301.63% |
| Capital Expenditure | -545.95% | 84.71% | -426.09% | 81.82% | -502.38% |
| Sale of Property, Plant, and Equipment | -95.65% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,600.00% | 94.21% | -426.09% | 81.82% | -502.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 51.28% | 0.00% | -2.63% | 0.00% | 0.00% |
| Issuance of Common Stock | -100.00% | -98.55% | 762.50% | 300.00% | -84.21% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 47.22% | -121.43% | 1,300.00% | 56.25% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -62.35% | 23.22% | -435.00% | -91.80% | 1,369.42% |